But this is where caution matters
About the IMPACT Phase 2b Study The randomized, placebo-controlled, double-blind IMPACT Phase 2b trial ( NCT05989711 ) enrolled 212 participants with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis stages F2 or F3, with and without diabetes
Semaglutide is a medication used for two primary purposes: managing type 2 diabetes and aiding in weight loss
If you have concerns about bone health, discuss them with your healthcare provider
Some medications, such as Ozempic and Trulicity, are covered under the Pharmaceutical Benefits Scheme (PBS) for people with type 2 diabetes who meet certain criteria
Some protocols combine all four peptides for comprehensive recovery support, though this increases both complexity and cost